Rate each area to see where you stand
Headline results from ESSENCE, which formed the basis of that 2025 approval, included: About 63 percent of semaglutide-treated patients reached resolution of steatohepatitis without worsening of liver fibrosis at 72 weeks Approximately 37 percent showed measurable improvement in liver fibrosis (the scarring that drives long-term liver damage) Mean body-weight reduction reached roughly 10 percent over 72 weeks of weekly subcutaneous semaglutide Gastrointestinal symptoms (nausea, early fullness, mild diarrhea) were the most common side effects, generally manageable with gradual dose escalation Source: FDA Wegovy approval materials, 2025 (FDA Drugs) The SLIM LIVER Trial and What It Found in People with HIV The ESSENCE numbers above come from the general MASH population, not specifically from people living with HIV
The goal is to provide a detailed, clear, and straightforward look at these topics based on the information available from medical research
Its here that they upregulate the production of insulin and improve the health and activity of beta cells responsible for insulin creation when blood sugar increases.12 Tirzepatide also influences alpha cells in the pancreas responsible for creating glucagon, a kind of check against insulin that helps increase blood glucose as needed.13 Digestive tract Central nervous system GLP-1 RAs impact the central nervous system in numerous ways, but one of the most important is their ability to influence satiety the feeling of being full and satisfied.16 Satiety is a complex hormonal state, and when these medications affect it, you tend to feel fuller sooner and stay feeling full for longer, ultimately leading to a reduction in food intake
One word youll hear thrown around when comparing different forms of semaglutide is bioavailability. This refers to the proportion of the drug that successfully enters the bloodstream and becomes active in the body after its administered
For many patients, gastrointestinal side effects gradually improve as the body adapts to the medication, though the timeline varies by product and individual
